A breakthrough in prostate cancer treatment has seen a drug shrink tumours in advanced disease ...

Daiichi Sankyo buys solid tumour ADC from Glycotope for $132.5m Daiichi Sankyo has finalised the acquisition of intellectual ...

A breakthrough experimental drug has shown promising results in shrinking advanced prostate cancer tumours, offering new hope ...

The company has three clinical CAR-T programmes backed by its precision-targeting cellular system Imod platform technology.

The Royal Marsden is an excellent choice for the Prince and Princess of Wales as they take the next step in their deeply ...

The doctor explained that link between spots and the pituitary gland lies in the fact that pituitary tumour produces excess ...

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients' cancer without aggressive surgery.

Fearne Cotton has shared a candid insight into her life, weeks after confirming that she and her husband Jesse Wood had ...

US-based Normunity has raised $75m in a Series B funding round to support the clinical development of its lead programme, NRM-823, a potential first-in-class T-cell engager (TCE) targeting solid ...

In tests conducted on mice, untreated tumours doubled in size within 38 days. However, among those treated with NXP800, only about one-third of tumours reached this size in the same timeframe. The ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...